Burosumab Biosimilar (FGF23 Reference Antibody)
Burosumab is a human fibroblast growth factor 23 (FGF23) neutralizing antibody that can be used for the research of X-linked hypophosphatemia (XLH) and tumor-induced osteomalacia.
Product Specifications
Target
Burosumab Biosimilar (Anti-FGF23 Reference Antibody)
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Stem Cell & Developmental Biology
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
